The global medical cannabis market is on a steep growth trajectory, with increasing legalization efforts, evolving public perceptions, and advancements in scientific research all contributing to its expansion. In 2024, the market was valued at approximately USD 12.65 billion and is poised for significant growth, projected to achieve a market size of USD 108.72 billion by 2034, representing a robust compound annual growth rate (CAGR) of 24.00%. This article delves into the drivers behind this explosive growth, key market trends, the leading players, and the overall future outlook for the medical cannabis market.

The Global Medical Cannabis Market

Medical cannabis refers to the use of cannabis and its constituent cannabinoids for medicinal purposes. The plant contains over 100 bioactive compounds, the most notable being THC (tetrahydrocannabinol) and CBD (cannabidiol), which have shown efficacy in treating a variety of medical conditions, such as chronic pain, epilepsy, multiple sclerosis, and certain mental health disorders.

As legal frameworks evolve across different regions, the demand for medical cannabis products continues to soar. Countries around the world are increasingly recognising the therapeutic benefits of cannabis, which is influencing its availability, consumption, and acceptance in the healthcare space. Additionally, research and clinical trials into cannabis-based therapies are progressing rapidly, providing further impetus for market growth.

Get a Free Sample Report with Table of Contents : https://www.expertmarketresearch.com/reports/medical-cannabis-market/requestsample

Key Drivers of Market Growth

The continued growth of the global medical cannabis market can be attributed to several key factors:

1. Legalization of Cannabis Across the Globe

   • One of the most significant factors driving market growth is the increasing legalization of cannabis for medicinal use. Countries such as Canada, Germany, and certain US states have already legalised cannabis for medicinal use, paving the way for further expansion in the industry. As more countries review and amend their cannabis policies, the market is expected to grow substantially.
   • In 2024, with more regions softening their stance on cannabis, the market is experiencing increased demand for both prescription-based and over-the-counter cannabis products.

2. Growing Acceptance of Cannabis in Medical Treatments

   • Public perception of cannabis has shifted dramatically in recent years. What was once considered a taboo substance is now increasingly viewed as a legitimate treatment option for various medical conditions. This is partly due to widespread media coverage and the success of clinical trials showing the benefits of cannabis in pain management, anxiety treatment, and alleviating the symptoms of neurodegenerative diseases.
   • Moreover, the rising prevalence of chronic conditions such as arthritis, cancer, and neurological disorders has increased the demand for alternative therapies, further fuelling the market growth.

3. Advancements in Research and Development

   • With scientific research advancing rapidly, more evidence is emerging that supports the efficacy of medical cannabis in treating a variety of medical conditions. Companies and research institutions are investing heavily in studies exploring the medical benefits of cannabinoids like THC, CBD, and other lesser-known compounds found in cannabis.
   • These advancements have contributed to a wider range of cannabis-based treatments available to patients, increasing the attractiveness of medical cannabis as a therapeutic option.

4. Rising Number of Medical Cannabis Patients

   • As the legalization of cannabis becomes more widespread, the number of patients seeking medical cannabis prescriptions is also on the rise. Patients suffering from conditions such as epilepsy, chronic pain, and cancer are increasingly turning to cannabis-based treatments as a safer alternative to traditional pharmaceuticals, which may carry a higher risk of addiction and adverse side effects.

5. Favourable Regulatory Environment

   • In regions where cannabis has been legalised, governments are implementing favourable regulatory frameworks to ensure the proper distribution and consumption of medical cannabis. This includes regulations that ensure patient safety, product quality, and the protection of public health, which in turn bolsters market confidence.

Key Market Trends

Several trends are shaping the trajectory of the global medical cannabis market:

1. Shift Towards Cannabis-based Pharmaceuticals

   • Over the years, there has been a marked shift towards the pharmaceuticalization of cannabis, with the development of cannabis-based drugs and treatments gaining traction. This includes FDA-approved drugs such as Epidiolex, a CBD-based treatment for epilepsy, and Sativex, a THC-based treatment for multiple sclerosis.
   • The transition from recreational cannabis to more medical and scientifically-backed cannabis products signals a maturing market, attracting large pharmaceutical companies and healthcare professionals.

2. Increased Focus on Cannabidiol (CBD) Products

   • CBD, a non-psychoactive compound found in cannabis, has garnered widespread attention for its potential therapeutic benefits. Unlike THC, CBD does not produce a “high” and is used for a variety of medical conditions, including pain relief, anxiety management, and skin care.
   • As a result, the demand for CBD-based products is expected to rise significantly, leading to the development of a wide range of CBD-infused oils, capsules, creams, and edibles. This trend is particularly strong in markets like the United States and Europe.

3. Expansion in the European Market

   • Europe has emerged as one of the key regions for medical cannabis market growth. Germany, in particular, has become a leader in medical cannabis adoption, with a well-established market for both prescription cannabis and CBD products.
   • The European Medicines Agency (EMA) has also approved cannabis-based medicines, providing a further boost to the market. As more European countries consider legalising medical cannabis, the regional market is expected to experience rapid growth in the coming years.

4. Telemedicine and Cannabis Clinics

   • With the rise of telemedicine and digital health platforms, patients now have the ability to consult with doctors remotely and obtain prescriptions for medical cannabis. Additionally, the proliferation of dedicated cannabis clinics is making it easier for patients to access medical cannabis treatments in a regulated environment.
   • This trend is expected to drive the accessibility and convenience of medical cannabis, further contributing to its adoption.

Segmentation of the Global Medical Cannabis Market

The medical cannabis market can be segmented based on the following factors:

1. By Product Type

   • Cannabidiol (CBD): The demand for CBD products, including oils, tinctures, edibles, and topicals, is growing rapidly. This segment is likely to dominate the market due to CBD’s wide range of potential medical benefits.
     
     
   • Tetrahydrocannabinol (THC): THC-based products, including capsules, oils, and smokable forms of cannabis, continue to be popular for their efficacy in treating conditions such as chronic pain, muscle spasms, and nausea.
     
     
   • Other Cannabinoids: This includes lesser-known cannabinoids such as CBG (cannabigerol) and CBN (cannabinol), which are being explored for their therapeutic potential.

2. By Application

   • Chronic Pain: Medical cannabis is widely used to manage chronic pain, particularly for conditions like arthritis, fibromyalgia, and neuropathic pain.
     
     
   • Mental Health Disorders: Cannabis-based treatments are increasingly being used for anxiety, depression, PTSD, and insomnia.
     
     
   • Neurological Disorders: Conditions such as epilepsy, multiple sclerosis, and Parkinson’s disease benefit from cannabinoid-based treatments.
     
     
   • Cancer: Cannabis is used to alleviate cancer-related symptoms, including nausea, vomiting, and pain from chemotherapy.

3. By End-User

   • Hospitals Clinics: Medical cannabis is primarily prescribed through hospitals and healthcare facilities, where patients receive supervision and advice from medical professionals.
     
     
   • Retail Pharmacies: With the increasing availability of medical cannabis, retail pharmacies are becoming important distribution channels for cannabis-based products.

Key Players in the Global Medical Cannabis Market

The medical cannabis market is highly competitive, with numerous players involved in the cultivation, production, distribution, and sale of medical cannabis products. Some of the key players include:

1. Canopy Growth Corporation: One of the largest cannabis companies globally, Canopy Growth is a key player in both the medical and recreational cannabis markets. The company focuses on producing high-quality cannabis and cannabis-derived products.

2. Aurora Cannabis: Based in Canada, Aurora Cannabis is another industry leader known for its medical cannabis products. It operates in multiple countries, including Germany, where it supplies cannabis to patients in need.

3. Tilray, Inc.: Tilray is a leading global cannabis company, with a significant footprint in the medical cannabis market. The company has expanded its presence in various international markets and offers a range of medical cannabis products.

4. GW Pharmaceuticals: Known for developing Epidiolex, the first FDA-approved cannabis-based drug, GW Pharmaceuticals is at the forefront of the medical cannabis pharmaceutical space.

5. Cronos Group: A global cannabis company, Cronos Group has a diverse portfolio of medical cannabis products, ranging from cannabis oils to edibles and capsules.

6. Aphria Inc.: Aphria, now part of Tilray, has a strong presence in the medical cannabis market, offering a variety of medical cannabis products to patients around the world.

Challenges and Opportunities in the Medical Cannabis Market

While the medical cannabis market shows tremendous promise, it also faces challenges that could hinder its growth:

1. Regulatory and Legal Issues: One of the main obstacles is the lack of uniform regulations across countries. The inconsistent legal status of cannabis in various regions can complicate its distribution and adoption.

2. Social Stigma: Despite growing acceptance, cannabis still carries some social stigma in certain regions, which could hinder market growth.

3. Supply Chain Limitations: The cultivation and distribution of medical cannabis require strict regulation and oversight, which can pose logistical challenges for producers.

However, these challenges also present opportunities. The ongoing shift in public attitudes towards cannabis, coupled with increasing legalization efforts, is creating a burgeoning market for medical cannabis products. Additionally, advancements in cannabinoid research and the expansion of clinical evidence will likely open new avenues for cannabis-based therapies.

FAQs

1. What is the global medical cannabis market size in 2024?

• The global medical cannabis market size was valued at USD 12.65 billion in 2024.

2. What is the expected growth rate for the market?

• The market is expected to grow at a CAGR of 24.00% from 2025 to 2034.

3. Which countries are leading in the medical cannabis market?

• Canada, Germany, and certain states in the USA are leading the medical cannabis market.

4. What are the primary medical uses of cannabis?

• Cannabis is primarily used to treat chronic pain, mental health disorders, neurological diseases, and cancer symptoms.

5. Who are the key players in the medical cannabis market?

• Major players include Canopy Growth Corporation, Aurora Cannabis, Tilray, GW Pharmaceuticals, Cronos Group, and Aphria Inc.

Media Contact

Company Name: Claight Corporation
Contact Person: Stephen Grand, Corporate Sales Specialist — U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1–415–325–5166 | +44–702–402–5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
Aus Site: https://www.expertmarketresearch.com.au